Skip to content

Discriminant Ability of the Shock Index, Modified Shock Index, and Reverse Shock Index Multiplied by the Glasgow Coma Scale on Mortality in Adult Trauma Patients: A PATOS Study

Discriminant Ability of the Shock Index, Modified Shock Index, and Reverse Shock Index Multiplied by the Glasgow Coma Scale on Mortality in Adult Trauma Patients: A PATOS Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05549986
Enrollment
105641
Registered
2022-09-22
Start date
2016-01-01
Completion date
2020-12-31
Last updated
2022-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morality, Shock, Traumatic, Trauma

Keywords

Shock index(SI), Modified Shock Index (MSI), Reverse Shock Index Multiplied by the Glasgow Coma Scale (rSIG), Mortality, Pan-Asian Trauma Outcomes Study (PATOS)

Brief summary

We evaluated a cohort of adult trauma patients transported to emergency departments. The first vital signs were used to calculate the SI, MSI, and rSIG. The areas under the receiver operating characteristic curves (AUROCs) and test results were used to compare the discriminant performance of the indices on short-term mortality and poor functional outcome. A subgroup analysis of geriatric patients, traumatic brain injury, penetrating injury, and non-penetrating injury was performed.

Interventions

OTHERObservational

Observational

Sponsors

Mackay Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult patients (≥18 years) EMS-transported from January 2016 to December 2020

Exclusion criteria

* Patients with missing entries of age, sex, triage, SBP, DBP, HR, or GCS were excluded. * Entries with missing records of in-hospital mortality or 30-day mortality were excluded from the short-term mortality cohort analyses. * Patients without a Modified Rankin Scale (MRS) record at discharge were excluded from the functional outcome cohort analyses.

Design outcomes

Primary

MeasureTime frameDescription
Discriminant power of SI, MSI, and rSIG on short-term mortality for adult traumatic patients30 daysAUROC in associated with short-term mortality with SI, MSI, rSIG

Secondary

MeasureTime frameDescription
Discriminant power of SI, MSI, and rSIG on functional outcome for adult traumatic patientsWe defined no symptoms, no significant disability, slight disability, and moderate disability (MRS 0-3) as favorable functional outcomes and moderately severe disability, severe disability, and death (MRS 4-6) as poor functional outcomesAUROC in associated with functional outcome with SI, MSI, rSIG

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026